These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 21684486)
21. Infliximab for refractory ulcerative colitis. Chey WY; Hussain A; Ryan C; Potter GD; Shah A Am J Gastroenterol; 2001 Aug; 96(8):2373-81. PubMed ID: 11513177 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report. Baglieri F; Scuderi G Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408 [TBL] [Abstract][Full Text] [Related]
23. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis. Fratila OC; Craciun C J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047 [TBL] [Abstract][Full Text] [Related]
24. Infliximab for ulcerative colitis in children and adolescents. McGinnis JK; Murray KF J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529 [TBL] [Abstract][Full Text] [Related]
25. Infliximab in the treatment of steroid-dependent ulcerative colitis. Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236 [TBL] [Abstract][Full Text] [Related]
26. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936 [TBL] [Abstract][Full Text] [Related]
27. [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis]. Hejazi R; Colombel JF; Peyrin-Biroulet L Gastroenterol Clin Biol; 2008 Feb; 32(2):162-3. PubMed ID: 18387427 [No Abstract] [Full Text] [Related]
28. TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis. Olsen T; Goll R; Cui G; Christiansen I; Florholmen J Cytokine; 2009 May; 46(2):222-7. PubMed ID: 19286392 [TBL] [Abstract][Full Text] [Related]
29. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Leblanc S; Allez M; Seksik P; Flourié B; Peeters H; Dupas JL; Bouguen G; Peyrin-Biroulet L; Duclos B; Bourreille A; Dewit O; Bouhnik Y; Michetti P; Chaussade S; Saussure P; Mary JY; Colombel JF; Lémann M; Am J Gastroenterol; 2011 Apr; 106(4):771-7. PubMed ID: 21386832 [TBL] [Abstract][Full Text] [Related]
30. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks. Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832 [TBL] [Abstract][Full Text] [Related]
31. Infliximab as therapeutic option in steroid-refractory ulcerative colitis after kidney transplantation: case report. Temme J; Koziolek M; Bramlage C; Schaefer IM; Füzesi L; Ramadori G; Müller GA; Schwörer H Transplant Proc; 2010 Nov; 42(9):3880-2. PubMed ID: 21094876 [TBL] [Abstract][Full Text] [Related]
32. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England. Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973 [TBL] [Abstract][Full Text] [Related]
33. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis. Fanjiang G; Russell GH; Katz AJ J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):312-7. PubMed ID: 17325550 [TBL] [Abstract][Full Text] [Related]
34. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks. Baudet A; Colombel JF; Cortot A; Dupas JL; Brazier F; Savoye G; Lerebours E; Justum AM; Reimund JM Gastroenterol Clin Biol; 2010 Nov; 34(11):612-7. PubMed ID: 20832218 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients. Gavalas E; Kountouras J; Stergiopoulos C; Zavos C; Gisakis D; Nikolaidis N; Giouleme O; Chatzopoulos D; Kapetanakis N Hepatogastroenterology; 2007 Jun; 54(76):1074-9. PubMed ID: 17629042 [TBL] [Abstract][Full Text] [Related]
36. Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy. Rojas-Feria M; Eslam M; Castro-Fernández M; Guerrero P; Larraona-Moreno JL; Romero-Gómez M J Crohns Colitis; 2011 Dec; 5(6):608-11. PubMed ID: 22115382 [TBL] [Abstract][Full Text] [Related]
37. Adalimumab in ulcerative colitis: ready for prime time. Danese S Dig Liver Dis; 2013 Jan; 45(1):8-13. PubMed ID: 22766323 [TBL] [Abstract][Full Text] [Related]
38. Rescue with infliximab and surgical outcomes for refractory ulcerative colitis. Actis GC; Pellicano R; Pinna-Pintor M; Rizzetto M J Am Coll Surg; 2007 Oct; 205(4):e3-4. PubMed ID: 17903716 [No Abstract] [Full Text] [Related]
39. Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. Herrlinger KR; Barthel DN; Schmidt KJ; Büning J; Barthel CS; Wehkamp J; Stange EF; Fellermann K Aliment Pharmacol Ther; 2010 May; 31(9):1036-41. PubMed ID: 20175769 [TBL] [Abstract][Full Text] [Related]